New Study Evaluates the Use of Masimo PVi As an Indicator of Fluid Responsiveness to Guide GoalDirected Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
Masimo NASDAQ MASI today announced the findings of a prospective randomized study published in Perioperative Medicine in which Dr. Yu Wang and colleagues at institutions in Shenzhen Shaoguan and Guangzhou China evaluated the use of noninvasive continuous Masimo PVi.